Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

36.21
Delayed Data
As of Sep 30
 +0.50 / +1.40%
Today’s Change
25.98
Today|||52-Week Range
38.06
+12.31%
Year-to-Date
No recent news for Haemonetics Corp.

Today’s Trading

Previous close35.71
Today’s open36.06
Day’s range35.55 - 36.46
Volume382,210
Average volume (3 months)336,965
Market cap$1.9B
Dividend yield--
Data as of 4:02pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-440.62%
Earnings growth (this year)-11.96%
Earnings growth (next 5 years)+7.50%
Revenue growth (last year)+0.02%
P/E ratioNM
Price/Sales1.89
Price/Book2.56

Competitors

 Today’s
change
Today’s
% change
ICUIICU Medical Inc+1.39+1.11%
HYHHalyard Health Inc+0.76+2.24%
NXTMNxStage Medical Inc+0.44+1.79%
GMEDGlobus Medical Inc+0.22+0.98%
Data as of 4:02pm ET, 09/30/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)$0.35
Annual revenue (last year)$910.5M
Annual profit (last year)-$55.6M
Net profit margin-6.10%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Christopher Simon
Chief Financial Officer
William P. Burke
Corporate headquarters
Braintree, Massachusetts

Forecasts

Search for Jobs